dry%20eye%20syndrome
DRY EYE SYNDROME

Dry eye syndrome is a clinical condition wherein the patient experiences ocular and conjunctival irritation due to decreased tear production and/or excessive tear evaporation.
It is associated with increased osmolarity of the tear film and inflammation of the ocular surface.

Goal of treatments are to relieve symptoms of patients, to improve visual acuity & quality of life of patients, to restore ocular surface & tear film to normal homeostatic state and to correct the underlying defect.

Dry Eye Syndrome Drug Information

Drug Information

Indication: Temporary relief of discomfort due to minor eye irritation from exposure to wind, sun or other irritants. Prot...

GenTeal Gel
carbomer + hypromellose

Indication: Lubricant eye gel for wearers of all types of contact lenses.

Indication: Keratoconjunctival epithelial disorders resulting from Sjogren's & Sicca syndrome (dry eye) & extrinsi...

Indication: Management of acute & chronic anterior uveitis, iridocyclitis, iritis & cyclitis, herpes zoster ophtha...

Tears Naturale Free
dextran 70 + hydroxypropyl methylcellulose

Indication: Relief in both mucin & aqueous deficient dry eye syndromes & symptoms of severe keratoconjunctivitis s...

Tears Naturale II
dextran 70 + hydroxypropyl methylcellulose

Indication: Relief of burning & irritation due to dryness in eyes or exposure to wind or sun. Protectant against furth...

Indication: Vismed/Vismed Multi Lubrication of the eyes in case of dryness, burning sensation & ocular fatigue. Vismed...

Celluvisc
carboxymethylcellulose sodium
1  /  4
Editor's Recommendations
Most Read Articles
Pearl Toh, 3 days ago
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Audrey Abella, 5 days ago
Extremes of sleep duration (≤5 or ≥10 hours/day), which is a known mortality risk factor in the general population, may increase absolute mortality in adults with type 2 diabetes (T2D), a prospective study has shown.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Roshini Claire Anthony, 12 Oct 2020

Insulin icodec, an in-development basal insulin analogue administered once weekly, was as effective as once-daily insulin glargine in patients with type 2 diabetes (T2D) insufficiently controlled with metformin with or without a DPP-4* inhibitor, according to a phase II trial presented at EASD 2020.